Pyrimidines and their use as CXCR2 receptor antagonists

Details for Australian Patent Application No. 2007323335 (hide)

Owner Novartis AG

Inventors Porter, David; Press, Neil John; Hunt, Peter; Janus, Diana

Agent Davies Collison Cave

Pub. Number AU-A-2007323335

PCT Pub. Number WO2008/061740

Priority 06124683.1 23.11.06 EP

Filing date 21 November 2007

Wipo publication date 29 May 2008

International Classifications

C07D 239/56 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/061740 Priority application(s): WO2008/061740

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007323336-5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as CXCR2 antagonists

2007323316-Novel agrochemical formulations containing microcapsules